Sade Ofir, Fischel Daphna, Barak-Broner Noa, Halevi Shir, Gottfried Irit, Bar-On Dana, Sachs Stefan, Mirelman Anat, Thaler Avner, Gour Aviv, Kestenbaum Meir, Gana Weisz Mali, Anis Saar, Soto Claudio, Roitman Melanie Shanie, Shahar Shimon, Doppler Kathrin, Sauer Markus, Giladi Nir, Lev Nirit, Alcalay Roy N, Hassin-Baer Sharon, Ashery Uri
School of Neurobiology, Biochemistry, Biophysics, Life Sciences Faculty, Tel Aviv University, Tel Aviv, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Front Mol Neurosci. 2024 Sep 4;17:1431549. doi: 10.3389/fnmol.2024.1431549. eCollection 2024.
Alpha-synuclein (aSyn) aggregates in the central nervous system are the main pathological hallmark of Parkinson's disease (PD). ASyn aggregates have also been detected in many peripheral tissues, including the skin, thus providing a novel and accessible target tissue for the detection of PD pathology. Still, a well-established validated quantitative biomarker for early diagnosis of PD that also allows for tracking of disease progression remains lacking. The main goal of this research was to characterize aSyn aggregates in skin biopsies as a comparative and quantitative measure for PD pathology. Using direct stochastic optical reconstruction microscopy (STORM) and computational tools, we imaged total and phosphorylated-aSyn at the single molecule level in sweat glands and nerve bundles of skin biopsies from healthy controls (HCs) and PD patients. We developed a user-friendly analysis platform that offers a comprehensive toolkit for researchers that combines analysis algorithms and applies a series of cluster analysis algorithms (i.e., DBSCAN and FOCAL) onto STORM images. Using this platform, we found a significant decrease in the ratio of the numbers of neuronal marker molecules to phosphorylated-aSyn molecules, suggesting the existence of damaged nerve cells in fibers highly enriched with phosphorylated-aSyn molecules. Furthermore, our analysis found a higher number of aSyn aggregates in PD subjects than in HC subjects, with differences in aggregate size, density, and number of molecules per aggregate. On average, aSyn aggregate radii ranged between 40 and 200 nm and presented an average density of 0.001-0.1 molecules/nm. Our STORM analysis thus highlights the potential of our platform for identifying quantitative characteristics of aSyn distribution in skin biopsies not previously described for PD patients while offering valuable insight into PD pathology by elucidating patient aSyn aggregation status.
α-突触核蛋白(aSyn)在中枢神经系统中的聚集是帕金森病(PD)的主要病理标志。在包括皮肤在内的许多外周组织中也检测到了aSyn聚集,从而为检测PD病理提供了一种新的且易于获取的靶组织。然而,仍然缺乏一种经过充分验证的用于PD早期诊断的定量生物标志物,该标志物还能够追踪疾病进展。本研究的主要目标是将皮肤活检中的aSyn聚集作为PD病理的一种比较性和定量性指标进行特征描述。我们使用直接随机光学重建显微镜(STORM)和计算工具,在来自健康对照(HC)和PD患者的皮肤活检组织的汗腺和神经束中,对总aSyn和磷酸化aSyn进行了单分子水平成像。我们开发了一个用户友好的分析平台,为研究人员提供了一个综合工具包,该工具包结合了分析算法,并将一系列聚类分析算法(即DBSCAN和FOCAL)应用于STORM图像。使用这个平台,我们发现神经元标记分子与磷酸化aSyn分子数量的比率显著降低,这表明在高度富集磷酸化aSyn分子的纤维中存在受损的神经细胞。此外,我们的分析发现,PD受试者中的aSyn聚集体数量高于HC受试者,聚集体在大小、密度和每个聚集体的分子数量上存在差异。平均而言,aSyn聚集体半径在40至200nm之间,平均密度为0.001 - 0.1个分子/nm。因此,我们的STORM分析突出了我们的平台在识别皮肤活检中aSyn分布的定量特征方面的潜力,这些特征此前尚未在PD患者中描述过,同时通过阐明患者的aSyn聚集状态,为PD病理提供了有价值的见解。